
Share on:
Collagen Solutions completed the final patient assessment in the eight-year extension clinical study of 15 patients who received a ChondroMimetic implant for the repair of cartilage defects in the knee.
With the last patient enrolled, data is being compiled and audited for submission as part of a package for regulatory approval and re-establishment of the CE mark, with ex-U.S. commercialization expected in mid-2018.
Collagen Solutions is a global supplier, developer and manufacturer of medical grade collagen, tissues and related medical devices and components for use in regenerative medicine, medical devices and in vitro diagnostics and research.
Source: Collagen Solutions
RELATED ARTICLES
Autocam Medical Announces $70 Million Manufacturing Expansion
Jun 17 2025 , Julie A. Vetalice
Strategic Expansion at the Heart of German Precision Manufacturing
Jun 08 2025 , Acrotec Medtech